Most of the tumors resulting from dual loss of G6pc3 or Ccdc108 and Trp53 were sarcomas; however, mixed lesions comprising both sarcomas and carcinomas were also present in these groups (Figure 5, D and E, and Supplemental Table 9). This evidence concerns the gene G6PC3 and sarcoma.